|
NL297170A
(enExample)
|
1963-04-04 |
1900-01-01 |
|
|
|
US3558618A
(en)
|
1968-04-01 |
1971-01-26 |
Dow Chemical Co |
Novel 4h-pyrazino(1,2-a)pyrimidine-4-ones
|
|
GB1383409A
(en)
|
1972-09-09 |
1974-02-12 |
Pfizer Ltd |
Derivatives of 2-amino- and 4-amino-quinazoline and pharmaceutical compositions containing them
|
|
US4122274A
(en)
|
1977-05-25 |
1978-10-24 |
Bristol-Myers Company |
3-Tetrazolo-5,6,7,8-substituted-pyrido[1,2-a]pyrimidin-4-ones
|
|
JPS56150091A
(en)
|
1980-03-28 |
1981-11-20 |
Janssen Pharmaceutica Nv |
3-(1-piperidinylalkyl)-4h-pyrido(1,2-a)pyrimidine- 4-one derivative and its manufacture
|
|
US4342870A
(en)
|
1980-03-28 |
1982-08-03 |
Janssen Pharmaceutica N.V. |
Novel 3-(1-piperidinylalkyl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives
|
|
JPS5852307A
(ja)
|
1981-09-22 |
1983-03-28 |
Hitachi Chem Co Ltd |
水分散樹脂組成物
|
|
US5089633A
(en)
|
1987-04-28 |
1992-02-18 |
Georgia Tech Research Corporation |
Substituted isocoumarins
|
|
US5599816A
(en)
|
1990-05-02 |
1997-02-04 |
Abbott Laboratories |
Quinolizinone type compounds
|
|
EP0640083A1
(en)
|
1992-05-13 |
1995-03-01 |
E.I. Du Pont De Nemours And Company |
Substituted pyrido 1,2-a]pyrimidinone derivatives as fungicides
|
|
DE69435005T2
(de)
|
1993-05-11 |
2008-04-17 |
The University Of North Carolina At Chapel Hill |
Antisense Oligonukleotide die anomales Splicing verhindern und deren Verwendung
|
|
KR19990022524A
(ko)
|
1995-06-06 |
1999-03-25 |
웨인스톡 스티븐 에프. |
퀴놀리지논형화합물
|
|
US5916916A
(en)
|
1996-10-10 |
1999-06-29 |
Eli Lilly And Company |
1-aryloxy-2-arylnaphthyl compounds, intermediates, compositions, and methods
|
|
US5869500A
(en)
|
1996-12-13 |
1999-02-09 |
Hoffmann-La Roche Inc. |
Pyridone compounds useful in treating Alzheimer's disease
|
|
CA2269561C
(en)
|
1998-04-22 |
2007-06-05 |
Dainippon Ink And Chemicals, Inc. |
Naphthalene derivative and liquid crystal composition comprising the same
|
|
AU5991699A
(en)
|
1998-09-21 |
2000-04-10 |
Biochem Pharma Inc. |
Quinolizinones as integrin inhibitors
|
|
US6214986B1
(en)
|
1998-10-07 |
2001-04-10 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of bcl-x expression
|
|
US6172216B1
(en)
|
1998-10-07 |
2001-01-09 |
Isis Pharmaceuticals Inc. |
Antisense modulation of BCL-X expression
|
|
US6210892B1
(en)
|
1998-10-07 |
2001-04-03 |
Isis Pharmaceuticals, Inc. |
Alteration of cellular behavior by antisense modulation of mRNA processing
|
|
WO2001030757A1
(en)
|
1999-10-28 |
2001-05-03 |
Microcide Pharmaceuticals, Inc. |
Drug discharge pump inhibitors
|
|
CN1891693A
(zh)
|
2000-01-24 |
2007-01-10 |
基纳西亚股份有限公司 |
用于治疗的吗啉代基取代的化合物
|
|
CA2437942C
(en)
|
2000-11-09 |
2013-06-11 |
Cold Spring Harbor Laboratory |
Chimeric molecules to modulate gene expression
|
|
US6774134B2
(en)
|
2000-12-20 |
2004-08-10 |
Bristol-Myers Squibb Company |
Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
|
|
US6989385B2
(en)
|
2000-12-21 |
2006-01-24 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
US20050009843A1
(en)
|
2001-04-26 |
2005-01-13 |
Kiyoshi Nakayama |
Medicine for inhibiting drug elimination pump
|
|
ATE466581T1
(de)
|
2001-12-07 |
2010-05-15 |
Vertex Pharma |
Verbindungen auf pyrimidin-basis als gsk-3-hemmer
|
|
GB0205281D0
(en)
|
2002-03-06 |
2002-04-17 |
Novartis Ag |
Organic compounds
|
|
AU2003256755A1
(en)
|
2002-07-24 |
2004-02-09 |
Ptc Therapeutics, Inc. |
Ureido substituted benzoic acid compounds, their use for nonsense suppression and the treatment of diseases caused by such mutations
|
|
JP4711391B2
(ja)
*
|
2002-09-30 |
2011-06-29 |
ニューロサーチ、アクティーゼルスカブ |
新規１，４−ジアザビシクロアルカン誘導体及びその製造方法
|
|
EP1785425B1
(en)
|
2002-09-30 |
2009-03-25 |
NeuroSearch A/S |
1,4-Diazabicycloalkane derivatives, their preparation and use
|
|
US20070078144A1
(en)
|
2003-01-29 |
2007-04-05 |
Stockwell Brent R |
Agents for treating neurodegenerative diseases
|
|
CN1809563A
(zh)
|
2003-06-20 |
2006-07-26 |
希龙公司 |
吡啶并[1,2－a]嘧啶－4－酮化合物用作抗癌药
|
|
GB0315494D0
(en)
|
2003-07-02 |
2003-08-06 |
Biofocus Plc |
Compounds which bind to the active site of protein kinase enzymes
|
|
JP2007501189A
(ja)
|
2003-08-01 |
2007-01-25 |
ジェネラブス テクノロジーズ，インコーポレイテッド |
フラビウイルス科に対する二環式イミダゾール誘導体
|
|
US7160888B2
(en)
|
2003-08-22 |
2007-01-09 |
Warner Lambert Company Llc |
[1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
|
|
US20050074801A1
(en)
|
2003-09-09 |
2005-04-07 |
Monia Brett P. |
Chimeric oligomeric compounds comprising alternating regions of northern and southern conformational geometry
|
|
US20050137203A1
(en)
|
2003-12-22 |
2005-06-23 |
Jianguo Ji |
3-quinuclidinyl amino-substituted biaryl derivatives
|
|
US7655657B2
(en)
*
|
2003-12-22 |
2010-02-02 |
Abbott Laboratories |
Fused bicycloheterocycle substituted quinuclidine derivatives
|
|
US20050245531A1
(en)
|
2003-12-22 |
2005-11-03 |
Abbott Laboratories |
Fused bicycloheterocycle substituted quinuclidine derivatives
|
|
US7309699B2
(en)
|
2003-12-22 |
2007-12-18 |
Abbott Laboratories |
3-Quinuclidinyl amino-substituted biaryl derivatives
|
|
NZ551468A
(en)
|
2003-12-24 |
2010-05-28 |
Biota Scient Management |
Polycyclic agents for the treatment of respiratory syncytial virus infections
|
|
SE0400184D0
(sv)
|
2004-01-30 |
2004-01-30 |
Fyrkloevern Scandinavia Ab |
New therapeutical use
|
|
TW200536830A
(en)
|
2004-02-06 |
2005-11-16 |
Chugai Pharmaceutical Co Ltd |
1-(2H)-isoquinolone derivative
|
|
EP1732560A4
(en)
|
2004-04-08 |
2010-08-18 |
Neurogen Corp |
SUBSTITUTED CINNOLINE-4-YLAMINE
|
|
ATE373659T1
(de)
|
2004-05-04 |
2007-10-15 |
Warner Lambert Co |
Pyrrolylsubstituierte pyrido(2,3-d)pyrimidin-7- one und derivate davon als therapeutische mittel
|
|
AU2006206446A1
(en)
|
2005-01-21 |
2006-07-27 |
Janssen Pharmaceutica N.V. |
Novel heterocyclic benzo[c]chromene derivatives useful as modulators of the estrogen receptors
|
|
US7879992B2
(en)
|
2005-01-31 |
2011-02-01 |
Isis Pharmaceuticals, Inc. |
Modification of MyD88 splicing using modified oligonucleotides
|
|
JP2006219453A
(ja)
|
2005-02-14 |
2006-08-24 |
Tokyo Univ Of Pharmacy & Life Science |
キノリン環を母核とする金属識別型二波長性蛍光分子
|
|
US7563601B1
(en)
|
2005-06-01 |
2009-07-21 |
City Of Hope |
Artificial riboswitch for controlling pre-mRNA splicing
|
|
MX2007015675A
(es)
|
2005-07-04 |
2008-02-20 |
Novo Nordisk As |
Antagonistas del receptor de histamina h3.
|
|
WO2007047913A2
(en)
|
2005-10-20 |
2007-04-26 |
Isis Pharmaceuticals, Inc |
Compositions and methods for modulation of lmna expression
|
|
WO2007058894A2
(en)
|
2005-11-10 |
2007-05-24 |
The University Of North Carolina At Chapel Hill |
Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease
|
|
EP1991677A2
(en)
|
2006-01-26 |
2008-11-19 |
Isis Pharmaceuticals, Inc. |
Compositions and their uses directed to huntingtin
|
|
AU2007211082B2
(en)
|
2006-01-27 |
2012-09-27 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds and compositions for the use in modulation of microRNAs
|
|
AR059339A1
(es)
|
2006-02-09 |
2008-03-26 |
Chugai Pharmaceutical Co Ltd |
Derivados de la cumarina para trastornos proliferativos de celulas, composicion farmaceutica y agente terapeutico que los contiene
|
|
US8110681B2
(en)
*
|
2006-03-17 |
2012-02-07 |
The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Compounds for the treatment of spinal muscular atrophy and other uses
|
|
WO2007130383A2
(en)
|
2006-04-28 |
2007-11-15 |
Northwestern University |
Compositions and treatments using pyridazine compounds and secretases
|
|
US20080247964A1
(en)
*
|
2006-05-08 |
2008-10-09 |
Yuelian Xu |
Substituted azaspiro derivatives
|
|
TW200812588A
(en)
|
2006-05-15 |
2008-03-16 |
Neurogen Corp |
CRF1 receptor ligands comprising heteroaryl fused bicycles
|
|
WO2007135121A1
(en)
|
2006-05-23 |
2007-11-29 |
Neurosearch A/S |
Novel 8,10-diaza-bicyclo[4.3.1]decane derivatives and their medical use
|
|
DE602007006835D1
(de)
|
2006-07-20 |
2010-07-08 |
Amgen Inc |
Substituierte pyridonverbindungen und anwendungsverfahren
|
|
US8337941B2
(en)
|
2006-07-27 |
2012-12-25 |
The Trustees Of Columbia University In The City Of New York |
Fluorescent substrates for monoamine transporters as optical false neurotransmitters
|
|
WO2008049864A1
(en)
|
2006-10-25 |
2008-05-02 |
Neurosearch A/S |
Oxadiazole and thiadiazole compounds and their use as nicotinic acetylcholine receptor modulators
|
|
US8314119B2
(en)
*
|
2006-11-06 |
2012-11-20 |
Abbvie Inc. |
Azaadamantane derivatives and methods of use
|
|
JP5208962B2
(ja)
|
2006-12-22 |
2013-06-12 |
アベキサ・リミテッド |
二環式ピリミジノンおよびその使用
|
|
US20080171792A1
(en)
|
2006-12-28 |
2008-07-17 |
Jobdevairakkam Christopher New |
Use of highly concentrated formulations of 4-phenylbutyrate for treatment of certain disorders
|
|
FR2914188B1
(fr)
|
2007-03-28 |
2012-06-22 |
Trophos |
Nouvelle composition a base d'oxime de cholest-4-en-3-one
|
|
EP2014656A3
(en)
*
|
2007-06-11 |
2011-08-24 |
High Point Pharmaceuticals, LLC |
New heteocyclic h3 antagonists
|
|
HUE025976T2
(en)
|
2007-09-27 |
2016-05-30 |
Fund Centro Nac De Investig Oncologicas Carlos Iii |
Imidazolothiadiazoles for use as protein kinase inhibitors
|
|
EP2215074B1
(en)
|
2007-09-27 |
2014-02-19 |
The United States of America, as Represented by the Secretary, Department of Health and Human Services |
Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
|
|
US8153813B2
(en)
|
2007-12-20 |
2012-04-10 |
Abbott Laboratories |
Benzothiazole and benzooxazole derivatives and methods of use
|
|
US8993580B2
(en)
|
2008-03-14 |
2015-03-31 |
Intellikine Llc |
Benzothiazole kinase inhibitors and methods of use
|
|
WO2009126635A1
(en)
|
2008-04-09 |
2009-10-15 |
Abbott Laboratories |
2-amino-benzothiazole derivates useful as inhibitors of rock kinases
|
|
US20090264433A1
(en)
|
2008-04-21 |
2009-10-22 |
Institute For Oneworld Health |
Compounds, Compositions and Methods Comprising Triazine Derivatives
|
|
WO2009151546A2
(en)
|
2008-05-27 |
2009-12-17 |
Ptc Therapeutics, Inc. |
Methods for treating spinal muscular atrophy
|
|
MX2010014394A
(es)
|
2008-06-20 |
2011-05-19 |
Rottapharm Spa |
Derivados de 6-1h-imidazo-quinazolina y quinolinas, nuevos inhibidores de monoamina oxidasa y ligandos del receptor de imidazolina.
|
|
EP2138493A1
(en)
|
2008-06-26 |
2009-12-30 |
Sanofi-Aventis |
Substituted pyrimidone derivatives
|
|
PL2212324T3
(pl)
|
2008-07-02 |
2014-11-28 |
Avexa Ltd |
Związki posiadające właściwości przeciwwirusowe
|
|
WO2010019243A1
(en)
|
2008-08-13 |
2010-02-18 |
Ptc Therapeutics, Inc. |
Methods for treating viral infections
|
|
GB2465405A
(en)
|
2008-11-10 |
2010-05-19 |
Univ Basel |
Triazine, pyrimidine and pyridine analogues and their use in therapy
|
|
WO2010071819A1
(en)
|
2008-12-19 |
2010-06-24 |
Schering Corporation |
Bicyclic heterocyclic derivatives and methods of use thereof
|
|
BRPI1008020A2
(pt)
*
|
2009-02-11 |
2016-03-15 |
Sunovion Pharmaceuticals Inc |
antagonistas e agonistas inversos h3 da histamina e métodos de uso dos mesmos
|
|
FR2945289A1
(fr)
|
2009-05-11 |
2010-11-12 |
Sanofi Aventis |
Derives de 2-cycloamino-5-(pyridin-4-yl)imidazo°2,1-b! °1,3,4!thiadiazole, leur preparation et leur application en therapeutique
|
|
AU2010262643B2
(en)
*
|
2009-06-19 |
2015-02-19 |
Abbvie Inc. |
Diazahomoadamantane derivatives and methods of use thereof
|
|
NZ714887A
(en)
|
2009-09-11 |
2019-07-26 |
Ionis Pharmaceuticals Inc |
Modulation of huntingtin expression
|
|
WO2011050245A1
(en)
|
2009-10-23 |
2011-04-28 |
Yangbo Feng |
Bicyclic heteroaryls as kinase inhibitors
|
|
WO2011057204A2
(en)
|
2009-11-06 |
2011-05-12 |
The Johns Hopkins University |
Lrrk2-mediated neuronal toxicity
|
|
EP2501231B1
(en)
|
2009-11-20 |
2016-12-21 |
Merck Sharp & Dohme Corp. |
Quinolizidinone carboxamide m1 receptor positive allosteric modulators
|
|
CN102812023A
(zh)
|
2010-01-13 |
2012-12-05 |
韩国巴斯德研究所 |
抗感染吡啶并(1,2-a)嘧啶类
|
|
CA2789038A1
(en)
|
2010-02-08 |
2011-08-11 |
Isis Pharmaceuticals, Inc. |
Selective reduction of allelic variants
|
|
JP2013518603A
(ja)
|
2010-02-08 |
2013-05-23 |
アイシス ファーマシューティカルズ， インコーポレーテッド |
反復伸張に関連する疾患または病態の治療に有用な方法および組成物
|
|
US8957040B2
(en)
|
2010-02-08 |
2015-02-17 |
Isis Pharmaceuticals, Inc. |
Selective reduction of allelic variants
|
|
WO2011149856A1
(en)
|
2010-05-24 |
2011-12-01 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of hcv ns5a
|
|
WO2012009367A1
(en)
*
|
2010-07-12 |
2012-01-19 |
Advanced Energy Industries, Inc. |
Power inverter systems with high-accuracy reference signal generation and associated methods of control
|
|
EP2595663A4
(en)
|
2010-07-19 |
2014-03-05 |
Isis Pharmaceuticals Inc |
MODULATION OF DYSTROPHIA MYOTONICA PROTEIN KINASE (DMPK) EXPRESSION
|
|
WO2012075393A2
(en)
*
|
2010-12-02 |
2012-06-07 |
President And Fellows Of Harvard College |
Activators of proteasomal degradation and uses thereof
|
|
WO2012104823A2
(en)
|
2011-02-04 |
2012-08-09 |
Novartis Ag |
Pyridopyrimidinone compounds in the treatment of neurodegenerative diseases
|
|
EP2673361B1
(en)
|
2011-02-08 |
2016-04-13 |
Ionis Pharmaceuticals, Inc. |
Oligomeric compounds comprising bicyclic nucleotides and uses thereof
|
|
US8703763B2
(en)
|
2011-03-02 |
2014-04-22 |
Hoffmann-La Roche Inc. |
Bridged piperidine derivatives
|
|
US9447075B2
(en)
|
2011-08-02 |
2016-09-20 |
The Brigham And Women's Hospital, Inc. |
Pyridazine derivatives as EAAT2 activators
|
|
US10202599B2
(en)
|
2011-08-11 |
2019-02-12 |
Ionis Pharmaceuticals, Inc. |
Selective antisense compounds and uses thereof
|
|
US8871756B2
(en)
|
2011-08-11 |
2014-10-28 |
Hoffmann-La Roche Inc. |
Compounds for the treatment and prophylaxis of Respiratory Syncytial Virus disease
|
|
US20130046093A1
(en)
|
2011-08-18 |
2013-02-21 |
Korea Institute Of Science And Technology |
Pharmaceutical compositions for preventing or treating degenerative brain disease and method of screening the same
|
|
WO2013033223A1
(en)
|
2011-08-29 |
2013-03-07 |
Isis Pharmaceuticals, Inc. |
Methods and compounds useful in conditions related to repeat expansion
|
|
US9662314B2
(en)
|
2011-10-21 |
2017-05-30 |
Tufts Medical Center, Inc. |
Compounds and methods for the treatment of muscular disease, and related screening methods
|
|
GB201119538D0
(en)
|
2011-11-10 |
2011-12-21 |
Viral Ltd |
Pharmaceutical compounds
|
|
BR112014012815A8
(pt)
*
|
2011-11-28 |
2017-06-20 |
Novartis Ag |
derivados de trifluormetil-oxadiazol e uso dos mesmos no tratamento de doença
|
|
KR102057351B1
(ko)
|
2011-12-30 |
2019-12-18 |
피티씨 테라퓨틱스, 인크. |
척수성 근위축증을 치료하기 위한 화합물
|
|
PL2809322T3
(pl)
|
2012-01-26 |
2019-11-29 |
Ptc Therapeutics Inc |
Związki do leczenia zaniku mięśni pochodzenia rdzeniowego
|
|
DK2812004T3
(en)
|
2012-02-10 |
2018-10-15 |
Ptc Therapeutics Inc |
COMPOUNDS FOR TREATMENT OF SPINAL MUSCLE DROPHY
|
|
CN104302181B
(zh)
|
2012-03-01 |
2017-09-15 |
Ptc医疗公司 |
用于治疗脊髓性肌萎缩的化合物
|
|
KR102109992B1
(ko)
|
2012-03-23 |
2020-05-13 |
피티씨 테라퓨틱스, 인크. |
척수성 근위축증을 치료하기 위한 화합물
|
|
MX371331B
(es)
|
2012-04-24 |
2020-01-27 |
Vertex Pharma |
Inhibidores de la proteina cinasa dependiente de acido desoxirribonucleico(adn-pk).
|
|
US8980934B2
(en)
*
|
2012-06-22 |
2015-03-17 |
University Health Network |
Kinase inhibitors and method of treating cancer with same
|
|
US9212209B2
(en)
|
2012-07-13 |
2015-12-15 |
Indiana University Research And Technology Corporation |
Screening methods for spinal muscular atrophy
|
|
US8729263B2
(en)
*
|
2012-08-13 |
2014-05-20 |
Novartis Ag |
1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions
|
|
EP3459549B1
(en)
|
2012-10-12 |
2022-04-06 |
Ionis Pharmaceuticals, Inc. |
Selective antisense compounds and uses thereof
|
|
EP2906255B1
(en)
|
2012-10-12 |
2023-02-22 |
Ionis Pharmaceuticals, Inc. |
Antisense compounds and uses thereof
|
|
US9227976B2
(en)
|
2012-10-25 |
2016-01-05 |
Usher Iii Initiative, Inc. |
Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
|
|
US9040712B2
(en)
|
2013-01-23 |
2015-05-26 |
Novartis Ag |
Thiadiazole analogs thereof and methods for treating SMN-deficiency-related-conditions
|
|
WO2014121287A2
(en)
|
2013-02-04 |
2014-08-07 |
Isis Pharmaceuticals, Inc. |
Selective antisense compounds and uses thereof
|
|
AU2014224975B2
(en)
|
2013-03-05 |
2017-09-14 |
Merck Patent Gmbh |
Triazolo(4,5-d)pyrimidine derivatives for the treatment of diseases such as cancer
|
|
EP2997028A1
(en)
|
2013-05-14 |
2016-03-23 |
F.Hoffmann-La Roche Ag |
Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection
|
|
WO2014209841A2
(en)
|
2013-06-25 |
2014-12-31 |
F. Hoffmann-La Roche Ag |
Compounds for treating spinal muscular atrophy
|
|
KR20210130843A
(ko)
*
|
2013-07-31 |
2021-11-01 |
노파르티스 아게 |
1,4-이치환된 피리다진 유사체 및 smn-결핍-관련 상태를 치료하기 위한 그의 용도
|
|
WO2015024876A2
(en)
|
2013-08-19 |
2015-02-26 |
F. Hoffmann-La Roche Ag |
Screening method
|
|
WO2015095446A1
(en)
|
2013-12-19 |
2015-06-25 |
Ptc Therapeutics, Inc. |
Methods for modulating the amount of rna transcripts
|
|
EP3082820B1
(en)
|
2013-12-19 |
2022-07-20 |
PTC Therapeutics, Inc. |
Methods for modulating the amount of rna transcripts
|
|
WO2015095449A1
(en)
|
2013-12-19 |
2015-06-25 |
Ptc Therapeutics, Inc. |
Methods for modulating the amount rna transcripts
|
|
BR112016016400A2
(pt)
|
2014-01-16 |
2017-10-03 |
Wave Life Sciences Ltd |
Composições de oligonucleotídeos quiralmente controlados, seu uso, sua composição farmacêutica, e métodos
|
|
WO2015107494A1
(en)
|
2014-01-17 |
2015-07-23 |
Novartis Ag |
1 -(triazin-3-yi_/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions thereof for inhibiting the activity of shp2
|
|
AR099134A1
(es)
|
2014-01-24 |
2016-06-29 |
Hoffmann La Roche |
Procedimiento para la preparación de n-[(3-aminooxetán-3-il)metil]-2-(1,1-dioxo-3,5-dihidro-1,4-benzotiazepín-4-il)-6-metil-quinazolín-4-amina
|
|
TWI674257B
(zh)
|
2014-03-14 |
2019-10-11 |
日商拉夸里亞創藥股份有限公司 |
作為ｔｒｐｍ８拮抗劑之氮雜螺衍生物
|
|
SI3143025T1
(sl)
|
2014-05-15 |
2020-01-31 |
F. Hoffmann-La Roche Ag |
Spojine za zdravljenje spinalne mišične atrofije
|
|
GB201410693D0
(en)
|
2014-06-16 |
2014-07-30 |
Univ Southampton |
Splicing modulation
|
|
US20170121197A1
(en)
|
2014-06-17 |
2017-05-04 |
Novozymes A/S |
Biological Phosphorus Removal from Wastewater
|
|
BR112016026951B1
(pt)
|
2014-06-25 |
2022-09-20 |
F. Hoffmann-La Roche Ag |
Imidazo[1,2-a]pirazin-1-il-benzamida, seu uso, e composições farmacêuticas
|
|
HRP20190992T1
(hr)
|
2014-12-24 |
2019-09-20 |
Uniqure Ip B.V. |
Suprimiranje gena za huntingtin inducirano s rnai
|
|
CA2973949C
(en)
|
2015-01-16 |
2023-07-11 |
The General Hospital Corporation |
Compounds for improving mrna splicing
|
|
WO2016128343A1
(en)
*
|
2015-02-09 |
2016-08-18 |
F. Hoffmann-La Roche Ag |
Compounds for the treatment of cancer
|
|
GB201502567D0
(en)
|
2015-02-16 |
2015-04-01 |
Sentinel Oncology Ltd |
Pharmaceutical compounds
|
|
GB201506933D0
(en)
|
2015-04-23 |
2015-06-10 |
Sentinel Oncology Ltd |
Pharmaceutical compounds
|
|
EP3298017B1
(en)
|
2015-05-20 |
2019-08-14 |
H. Hoffnabb-La Roche Ag |
Compounds for treating spinal muscular atrophy
|
|
EP4249472A3
(en)
|
2015-05-30 |
2023-12-13 |
PTC Therapeutics, Inc. |
Methods for modulating rna splicing
|
|
IL320434A
(en)
|
2015-07-22 |
2025-06-01 |
Wave Life Sciences Ltd |
Oligonucleotide preparations and methods
|
|
WO2017023987A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
|
|
US9920032B2
(en)
|
2015-10-02 |
2018-03-20 |
Incyte Corporation |
Heterocyclic compounds useful as pim kinase inhibitors
|
|
WO2017081111A1
(en)
|
2015-11-12 |
2017-05-18 |
F. Hoffmann-La Roche Ag |
Compounds for treating amyotrophic lateral sclerosis
|
|
JP6659841B2
(ja)
|
2015-11-12 |
2020-03-04 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
脊髄性筋萎縮症を処置するための組成物
|
|
WO2017097728A1
(en)
|
2015-12-10 |
2017-06-15 |
F. Hoffmann-La Roche Ag |
Bridged piperidine derivatives
|
|
IL294124B2
(en)
*
|
2015-12-10 |
2024-02-01 |
Ptc Therapeutics Inc |
Methods for treating huntington's disease
|
|
US10526345B2
(en)
|
2016-04-08 |
2020-01-07 |
Mankind Pharma Ltd. |
Compounds as GPR119 agonists
|
|
AR108325A1
(es)
|
2016-04-27 |
2018-08-08 |
Samumed Llc |
Isoquinolin-3-il carboxamidas y preparación y uso de las mismas
|
|
EP3452596A4
(en)
|
2016-05-04 |
2020-03-18 |
Wave Life Sciences Ltd. |
OLIGONUCLEOTIDE COMPOSITIONS AND RELATED METHODS
|
|
WO2017210134A1
(en)
|
2016-05-31 |
2017-12-07 |
Board Of Regents, University Of Texas System |
Heterocyclic inhibitors of ptpn11
|
|
WO2018022473A1
(en)
|
2016-07-25 |
2018-02-01 |
Wave Life Sciences Ltd. |
Phasing
|
|
TW202500565A
(zh)
|
2016-10-24 |
2025-01-01 |
美商傳達治療有限公司 |
Shp2磷酸酶抑制劑及其使用方法
|
|
WO2018187209A1
(en)
|
2017-04-03 |
2018-10-11 |
Acceleron Pharma Inc. |
Compositions and methods for treating spinal muscular atrophy
|
|
EP3630770B1
(en)
|
2017-05-26 |
2024-08-28 |
Relay Therapeutics, Inc. |
Pyrazolo[3,4-b]pyrazine derivatives as shp2 phosphatase inhibitors
|
|
US11407753B2
(en)
|
2017-06-05 |
2022-08-09 |
Ptc Therapeutics, Inc. |
Compounds for treating Huntington's disease
|
|
US11382918B2
(en)
|
2017-06-28 |
2022-07-12 |
Ptc Therapeutics, Inc. |
Methods for treating Huntington's Disease
|
|
WO2019005993A1
(en)
|
2017-06-28 |
2019-01-03 |
Ptc Therapeutics, Inc. |
METHODS OF TREATING HUNTINGTON'S DISEASE
|
|
WO2019028440A1
(en)
|
2017-08-04 |
2019-02-07 |
Skyhawk Therapeutics, Inc. |
METHODS AND COMPOSITIONS FOR MODULATING SPLICING
|
|
WO2019165073A1
(en)
|
2018-02-21 |
2019-08-29 |
Relay Therapeutics, Inc. |
Shp2 phosphatase inhibitors and methods of use thereof
|
|
US12138263B2
(en)
|
2018-03-21 |
2024-11-12 |
Relay Therapeutics, Inc. |
Pyrazolo[3,4-b]pyrazine SHP2 phosphatase inhibitors and methods of use thereof
|
|
AU2019240299B2
(en)
|
2018-03-21 |
2023-06-22 |
D.E. Shaw Research, Llc |
SHP2 phosphatase inhibitors and methods of use thereof
|
|
MX2020009957A
(es)
|
2018-03-27 |
2021-01-15 |
Ptc Therapeutics Inc |
Compuestos para el tratamiento de enfermedad de hungtinton.
|
|
EP3814360B8
(en)
|
2018-06-27 |
2024-11-06 |
PTC Therapeutics, Inc. |
Heteroaryl compounds for treating huntington's disease
|
|
EP3814345B8
(en)
|
2018-06-27 |
2024-10-30 |
PTC Therapeutics, Inc. |
Heteroaryl compounds for treating huntington's disease
|
|
PL3814357T3
(pl)
|
2018-06-27 |
2024-09-16 |
Ptc Therapeutics, Inc. |
Związki heterocykliczne i heteroarylowe do leczenia choroby huntingtona
|
|
WO2020231977A1
(en)
|
2019-05-13 |
2020-11-19 |
Ptc Therapeutics, Inc. |
Compounds for treating huntington's disease
|
|
WO2021007378A1
(en)
|
2019-07-11 |
2021-01-14 |
Ptc Therapeutics, Inc. |
Compounds for use in treating huntington's disease
|
|
AU2020377204A1
(en)
|
2019-11-01 |
2022-06-02 |
Novartis Ag |
The use of a splicing modulator for a treatment slowing progression of huntington's disease
|